Rare diseases
Investigational molecules
Locations
Back to Germany319 clinical trials in Regensburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
GermanyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
GermanyA study of rilvegostomig and ramucirumab in patients with advanced or metastatic non-small cell lung cancer
GermanyA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
GermanyA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
GermanyA Study of Cemiplimab Given Before Surgery in Patients with Early Stage Merkel Cell Carcinoma of the Skin
GermanyGermanyA Study of Pembrolizumab and Radiotherapy for Patients with Early-Stage Favorable Classic Hodgkin Lymphoma
GermanyA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
GermanyTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
GermanyStudy of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy
GermanyA Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of targeted therapies for HR-positive and HER2-negative variants. Research extends to lymphoma and leukemia treatments, with particular emphasis on combination therapies.
Multiple studies are evaluating novel drug combinations and their impact on patient survival rates.
Research focusing on preventive treatments for atopic dermatitis in high-risk pediatric populations, evaluating the effectiveness of early intervention strategies.
Studies aim to establish new preventive protocols for childhood dermatological conditions.
Investigations into treatments for pulmonary arterial hypertension and lung fibrosis, with emphasis on novel therapeutic approaches and drug safety profiles.
Current trials are exploring innovative treatments for various respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
